Supported by the phase 3 ALLEGORY trial, the application moves obinutuzumab closer to becoming a new standard for patients with active, autoantibody-positive SLE.
No increase seen in incidence of major bleeding, adverse events, or serious adverse events compared with placebo.
Older adults with adenoma at prior colonoscopy more likely to experience CRC but risk exceeded by competing risks for non-CRC death.
Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order aimed at boosting fede ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results